Compliance updated on Sep 10, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Biodesix Inc

BDSX ✓ COMPLIANT ☆ Track — members

NASDAQ · Healthcare · Healthcare Facilities & Services ·

USA Small Cap Analyst: BUY

Last Close

$28.56

▲ +3.10%

Market Cap $301.34M · Vol 36.47K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$301.34M

Small Cap

Div Yield

N/A

EPS Growth

+42.77%

YoY

RSI (14)

42.19

Momentum

Beta

0.55

vs Market

52W High

$31.31

8.78% below

52W Low

$5.26

442.97% above

Volume

36.47K

Avg 33.46K

P/B

N/A

Price-to-book

ROE

N/A

Return on equity

Free Float

53.66%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Biodesix Inc (BDSX) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does BDSX pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+5.47%

+19.00%

+86.30%

+65.18%

YTD

+320.00%

+335.37%

+2.73%

-83.88%

Financials & Valuation

TTM · Annual

Total Revenue	$88.50M
Net Income	$-35,265,000.00
Revenue Growth (YoY)	+34.18%
Gross Margin	81.11%
Operating Margin	-31.37%
Net Profit Margin	-39.85%
ROE	N/A
ROA · ROIC	-38.18% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	0.58
P/B	N/A
P/FCF	N/A
EPS Growth	+42.77%
Outstanding Shares	10.55M

Technical Indicators

50-Day SMA	$23.95
200-Day SMA	$15.67
RSI (14)	42.19
Beta	0.55
52-Week High	$31.31
52-Week Low	$5.26

Volume Today	36.47K
Avg Daily Volume (30D)	33.46K
Relative Volume	1.09x
Volatility (10D)	50.31
Volatility (30D)	84.15
Free Float	53.66%

Analyst Consensus

BUY

Current Price $28.56

Mean Target $32.80

52W Low$5.26 52W High$31.31

Current

Target

$5.26 $31.31

Current Analyst target

+14.85% upside potential · 7 analysts

Identifiers

ExchangeNASDAQ

FIGIBBG001V0G914

ISINUS09075X2071

CountryUSA

Sub-IndustryMedical & Diagnostic Laboratories

Earnings DateNov 2, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

NTRA Natera, Inc. -1.55% LH Labcorp Holdings Inc. +0.17% RDNT RadNet, Inc. -1.74% LALPATHLAB.NS Dr. Lal PathLabs Ltd -0.56% WGS GeneDx Holdings Corp. +2.94%

Company Profile

Biodesix, Inc. is a diagnostic solutions company. The Company's business includes Biodesix Lung Diagnostic Testing and Biodesix Development Services. Its Biodesix Lung Diagnostic Testing provides lung diagnostic testing services for healthcare providers through five blood-based tests. Its Biodesix Development Services supports global biopharmaceutical, life sciences, and research institutions with scientific, technological, and operational capabilities that enable the development of diagnostic tests, tools, and therapeutics. The Company offers Nodify Lung tests and IQLung tests that assess cancer risk and provide treatment guidance following a lung cancer diagnosis. The Nodify Lung tests include Nodify CDT and Nodify XL2 tests, which evaluate the risk of lung cancer in lung nodules. The GeneStrat ddPCR, GeneStrat NGS, and VeriStrat tests are used in the diagnosis of lung cancer to detect tumor mutations and assess the patient’s immune system status.